Delivery Order SPE2DB22D2005-SPE2DB24FJPL4
Award Date
7/1/24
Potential Completion Date
7/2/24
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Clindamycin Phosphate 1% Foam, 50 gm. The total ceiling value of the order is $1,077.81. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Clindamycin Phosphate 1% Foam, 100 gm. The contract has a ceiling value of $6,681.59 and an ultimate completion date of April 26, 2023. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4563335833 - Clindamycin Phosphate 1% Foam, 50 grams. The contract has a ceiling value of $1,568.55 and an ultimate completion date of January 17, 2024. This is a firm-fixed-price contract without any set-aside designations, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of Clindamycin Phosphate 1% Foam, 100 GM. The contract has a firm fixed price and a ceiling value of $1,081.02, with a performance period running through January 16, 2025. The award is not designated under any set-aside program. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award is for the delivery of Clindamycin Phosphate 1% Foam, 50 grams, to the Defense Logistics Agency (DLA) by Amerisourcebergen Drug Corp's Corporate Office division. The $1,130.90 firm-fixed-price delivery order contract has a completion date of May 17, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,428.66 firm fixed-price contract is for the delivery of Clindamycin Phosphate 1% Foam, a topical antibiotic medication, with a period of performance through October 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, with ID SPE2DB20D2104|SPE2DB25FMHLH, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,506.14 firm fixed price delivery order is for the supply of 4567174426 - Clindamycin Phosphate 1% Foam, 100GM. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,125.84 delivery order contract is for the provision of Clindamycin Phosphate 1% Foam, a pharmaceutical product. The contract is a Firm Fixed Price (FFP) agreement with a period of performance through February 9, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award is for the delivery of Clindamycin Phosphate 1% Foam, 50 grams, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. The contract has a ceiling value of $1,355.76 and was awarded on April 6, 2022, with an ultimate completion date of April 7, 2022. It is a delivery order...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Clindamycin Phosphate 1% Lotion 60 mL. The delivery order has a ceiling value of $1,242.61 and a completion date of April 15, 2024. AmerisourceBergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is issued under a much larger indefinite...